Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q1 EPS of ($0.59), $0.24 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Aspire Biopharma to acquire automotive supplier for $30 million
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results